Mikardis - drugs used to treat high blood pressure.
Pharmacological action Mikardisa
Mikardis dilates blood vessels and lowers the diastolic and systolic blood pressure, while it does not affect the heart rate and ion channels that regulate the activity of the cardiovascular system.
Reviews Mikardise confirm that its action develops in 3 hours, stable pressure drop observed after 4 weeks after starting the drug.
Antihypertensive effect lasts Mikardisa day. The active ingredient of the drug - telmisartan.
Analogs Mikardisa - drugs with the same active ingredient: Praytor and Telmisartan.
Mikardis indicated for the treatment of hypertension, essential hypertension, for the prevention of cardiovascular disease.
Good reviews of Mikardise, which was used for the treatment of patients with ischemia, stroke, peripheral artery disease in the past, Type II diabetes - such patients the drug helps to reduce the likelihood of developing cardiovascular disease.
Instructions Mikardisa: how to use
The tablets are one p / day 20-40mg. For medical reasons can be assigned dosage 80mg / day.
To prevent cardiovascular disease and reduce the risk of mortality recommended dosage is 80mg Mikardisa take means one p / day.
For patients with impaired renal function average mild adjust the dosage is not necessary. When kidney failure or dialysis at the beginning of therapy prescribed 20mg Mikardisa.
The recommended dosage for patients with mild, mild hepatic impairment - one 40 mg p / day.
For elderly patients do not need to adjust the dose.
During therapy monitor kidney function, blood pressure, check the level of the concentration of potassium in the blood.
Analogs Mikardisa used for the same therapeutic regimen.
Mikardis can cause dizziness, fatigue, anxiety, seizures, headaches, depression, insomnia, respiratory tract infections such as bronchitis, pharyngitis, sinusitis, and other, cough, chest pain and back pain, excessive lowering of pressure, palpitations, diarrhea, pain abdominal pain, nausea, elevated liver enzymes, arthralgia, myalgia, urinary duct, swelling, skin rash, hyperkalemia, hypercreatininemia, hyperuricemia, anemia, grippodobnye symptoms.
In overdose Mikardisa observed marked reduction of pressure. For the correction of symptomatic treatment. Hemodialysis, in this case considered to be ineffective.
Mikardis not appoint obstruction of the bile ducts, with hypersensitivity, during lactation, pregnancy. In addition to the instructions Mikardisa stated that it is contraindicated in children and adolescents with care prescribed for renal artery stenosis, kidney or liver failure.
When administering the drug into account that it increases the concentration of digoxin and lithium in the blood. The risk of hypotension raises Mikardisa combination with drugs with similar effects, diuretics.
Hyperkalemia may occur due to the simultaneous administration of the drug with potassium-sparing diuretics and potassium-containing drugs.